Public Health Policy In 2010: Research Funding And Regulations
Finding ways to fund research and regulating medication is critical to international public health policy and intellectual property rights specialists in 2010.
Intellectual Property Watch
Original news and analysis on international IP policy
UK IP Minister Lammy Backs EU Release Of ACTA Text
David Lammy, United Kingdom Minister for Intellectual Property, today said the UK supports the European Union’s position that the text of the Anti-Counterfeiting Trade Agreement (ACTA) should be made public. “The UK has long been in favour of greater transparency…
Lamy: IP Gaps “Illuminated,” But Not Narrower
World Trade Organization Director General Pascal Lamy has announced to member states that governments’ differences on two key intellectual property issues have been “better illuminated” by an ongoing informal consultation process, though he added, “I would not say that the…
Le Conseil des ADPIC envisage la tenue d’un atelier sur un amendement relatif à la santé publique
Le groupe Propriété Intellectuelle de l’Organisation Mondiale pour le Commerce s’est réuni plus brièvement que prévu, le 2 mars 2010, pour discuter d’un éventuel atelier sur un amendement visant à faciliter l’accès à des médicaments génériques abordables pour les pays dépourvus d’industrie pharmaceutique, d’une nouvelle proposition de la Bolivie, et de trois questions de propriété intellectuelle qui, bien qu’anciennes, n’ont pas connu de développement significatif.
Brazil Starts Public Consult On Retaliation Against US IP Rights
The Brazilian government today announced the start of a process of public consultation on suspension of concessions or obligations of intellectual property rights from the United States. The government on 15 March published a resolution of the Chamber of External…
AIDS Patients Protest EU-India Trade Agreement
Patients with HIV/AIDS today protested in New Delhi against negotiations for a European Union-India free trade agreement that they say will restrict access to cheaper versions of critical medicines in developing countries. Médecins Sans Frontières (MSF, or Doctors without Borders)…
European Generics Industry Calls For “Urgent Patent Reform”
“Competition and real innovation” will be increasingly difficult if the patent system in Europe is not reformed, the European Generic Medicines Association (EGA) said today at its “Legal Affairs Forum,” which took place on 11 March. The European Patent Office…
Indian Civil Society Raises Concerns Over US Industry-Sponsored IP Summits
Public interest groups in India are raising questions over annual summits involving Indian judges and policymakers that are being funded by major western industry groups, in particular pharmaceutical companies. At this year’s summit, held recently, a section of India’s patent law which prevents the extension of monopoly power for incremental innovations came under attack, the groups have said.
New US Senate Patent Reform Bill Brings Many Reactions
Reactions have emerged since last week’s release by United States Senate Judiciary Committee bipartisan leaders of details of compromise legislation to reform of US patent laws. Most are generally positive, signalling that a long-sought compromise might be near, but strong reservations remain among some stakeholders.
US On International Trade Crusade With New Agenda
The recently released US annual trade agenda shows an intention to conquer new international markets, strengthen the global trade system and enforce obligations and US intellectual property rights. The US also means to address what they consider as trade barriers. [Update: President Obama spoke on the trade agenda today, more below.]